我国药品流通领域改革政策研究评述——基于利益相关者博弈视角

发布时间：2018-05-16 02:24

本文选题：药品流通领域改革 + 政策评价　；参考：《中国卫生政策研究》2017年06期

【摘要】：药品流通领域改革是我国"三医联动"改革的关键环节。改革政策的制定、推行必然导致利益再分配。因此,从各利益主体博弈的视角对其进行评价,是全面理解改革过程中出现的非预期结果,从而科学决策政策走向,确保改革顺利推进的有效手段。本文通过梳理新医改以来药品流通领域改革政策及其研究文献,揭示现有研究存在的问题和不足,论证基于科学理论框架下的政策评价是判断改革目标是否实现的有力工具。将利益相关者理论和博弈理论引入药品流通领域进行政策评价,能够将复杂的影响因素在其理论框架下科学量化,从而揭示政策效果的因果机制,对药品流通领域改革政策有更清晰的解读和总结,为下一步政策走向提供科学合理的参考。
[Abstract]:The reform in the field of drug circulation is a key link in the reform of "three medical linkage" in our country. The formulation of reform policies, the implementation of which will inevitably lead to redistribution of interests. Therefore, it is an effective means to evaluate the stakeholders from the perspective of game theory, to understand the unexpected results in the process of reform, to make scientific policy decisions and to ensure the smooth progress of the reform. By combing the reform policy in the field of drug circulation since the new medical reform and its research literature, this paper reveals the problems and shortcomings of the existing research, and proves that the policy evaluation based on the scientific theory framework is a powerful tool to judge whether the reform goal can be achieved or not. Introducing stakeholder theory and game theory into the field of drug circulation for policy evaluation can scientifically quantify the complex influencing factors under its theoretical framework, thus revealing the causal mechanism of the policy effect. A clearer interpretation and summary of the reform policy in the field of drug circulation provides a scientific and reasonable reference for the next policy direction.
【作者单位】：武汉大学健康学院;
【分类号】：R95

【相似文献】